AAME

Atlantic American Corp. 10-Q Summary: Q2 2024

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2024. Atlantic American Corporation (AAME) is an insurance holding company operating through two primary segments: American Southern (property and casualty) and Bankers Fidelity (life and health). The company is classified as a non-accelerated filer and a smaller reporting company.

Key Financial Metrics

Note: Debt includes $4.0M revolving credit facility and $33.7M junior subordinated debentures.

Material Changes vs. Prior Period

• Revenue Decline: Net premiums decreased 2.3% in Q2 and 2.8% YTD compared to 2023. This was driven by a drop in Medicare supplement premiums (Bankers Fidelity) and a decline in automobile physical damage premiums due to a slowdown in the trucking industry (American Southern).
• Loss Experience: The company reported unfavorable loss development in both segments.
  • American Southern: Combined ratio worsened to 101.3% (Q2) and 99.1% (YTD) due to increased frequency and severity of claims in automobile liability.
  • Bankers Fidelity: Combined ratio worsened to 102.0% (Q2) and 106.2% (YTD) due to increased reserves in group life and higher paid claims in Medicare supplement lines.
• Investment Performance: Net investment income declined slightly. However, the company recognized unrealized gains on equity securities of $0.2M in Q2 and $0.1M YTD, contrasting with unrealized losses of $1.9M in the same period in 2023.
• Interest Expense: Increased 7.4% in Q2 and 10.6% YTD due to higher SOFR rates affecting the revolving credit facility and junior subordinated debentures.

Outlook, Risks, and Contingencies

• Internal Control Material Weakness: Management concluded that disclosure controls were not effective as of June 30, 2024, due to a material weakness in the design of controls surrounding the review of insurance reserves and deferred acquisition costs in the life and health segment. Remediation efforts are underway, with new analytical reports expected to be operational by September 30, 2024.
• Liquidity: Cash decreased by $7.1M YTD, primarily due to operating cash outflows and net investment purchases. The company maintains a $10M revolving credit facility (extended to March 2027) with $6M available. Statutory capital and surplus remain adequate ($52.0M for American Southern; $32.7M for Bankers Fidelity).
• Debt Covenants: The company must maintain a consolidated net worth of at least $64.2M and a debt-to-capital ratio below 35%. As of June 30, 2024, shareholders' equity was $100.7M, indicating compliance.
• Forward-Looking Risks: Results are subject to volatility in interest rates, credit spreads, and claim frequency/severity. The company notes that actual results could differ materially from forward-looking statements.

Investor Verification Checklist

• Reserve Adequacy: Verify the impact of the material weakness on the accuracy of life and health insurance reserves and deferred acquisition costs.
• Loss Trend Sustainability: Assess whether the unfavorable loss development in automobile liability and Medicare supplement lines is a temporary anomaly or a structural shift requiring rate adjustments.
• Interest Rate Sensitivity: Monitor the impact of sustained high SOFR rates on interest expense and the fair value of the fixed maturity portfolio (which holds significant unrealized losses).
• Remediation Timeline: Confirm the implementation of the new analytical reports and enhanced controls by the projected September 2024 deadline.
• Dividend Restrictions: Review the $8.8M threshold for subsidiary dividend payments requiring regulatory approval and the company's ability to fund parent-level obligations without external financing.